Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 997

1.

Aberration-resistible topological charge determination of annular-shaped optical vortex beams using Shack-Hartmann wavefront sensor.

Wang D, Huang H, Matsui Y, Tanaka H, Toyoda H, Inoue T, Liu H.

Opt Express. 2019 Mar 4;27(5):7803-7821. doi: 10.1364/OE.27.007803.

PMID:
30876337
2.

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.

Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Nakamuta M, Watanabe T, Michitaka K, Ikegami T, Nozaki A, Uojima H, Fukunishi S, Genda T, Abe H, Hotta N, Tsuji K, Ogawa C, Tachi Y, Shima T, Shimada N, Kondo C, Akahane T, Aizawa Y, Tanaka Y, Kumada T, Iwakiri K.

Aliment Pharmacol Ther. 2019 Mar 14. doi: 10.1111/apt.15218. [Epub ahead of print]

PMID:
30873651
3.

Establishment and characterization of Drosophila cell lines mutant for heparan sulfate modifying enzymes.

Nakato E, Liu X, Eriksson I, Yamamoto M, Kinoshita-Toyoda A, Toyoda H, Kjellén L, Li JP, Nakato H.

Glycobiology. 2019 Mar 14. pii: cwz020. doi: 10.1093/glycob/cwz020. [Epub ahead of print]

PMID:
30869121
4.

Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Takaguchi K, Toyoda H, Tsutsui A, Suzuki Y, Nakamuta M, Imamura M, Senoh T, Nagano T, Tada T, Tachi Y, Hiraoka A, Michitaka K, Shibata H, Joko K, Okubo H, Tsuji K, Takaki S, Watanabe T, Ogawa C, Chayama K, Kumada T, Kudo M, Kumada H.

J Gastroenterol. 2019 Mar 8. doi: 10.1007/s00535-019-01568-8. [Epub ahead of print]

PMID:
30848363
5.

Answer to the Letter to the Editor concerning "The association of back muscle strength and sarcopenia-related parameters in the patients with spinal disorders" by Toyoda H, et al. (Eur Spine J; doi.org/10.1007/s00586-018-5858-8).

Toyoda H, Hoshino M, Ohyama S, Terai H, Suzuki A, Yamada K, Takahashi S, Hayashi K, Tamai K, Hori Y, Nakamura H.

Eur Spine J. 2019 Mar 6. doi: 10.1007/s00586-019-05942-1. [Epub ahead of print] No abstract available.

PMID:
30840140
6.

Development of a scoring system for predicting adjacent vertebral fracture after balloon kyphoplasty.

Takahashi S, Hoshino M, Yasuda H, Hori Y, Ohyama S, Terai H, Hayashi K, Tsujio T, Kono H, Suzuki A, Tamai K, Toyoda H, Dohzono S, Sasaoka R, Kanematsu F, Nakamura H.

Spine J. 2019 Mar 1. pii: S1529-9430(19)30075-0. doi: 10.1016/j.spinee.2019.02.013. [Epub ahead of print]

PMID:
30831317
7.

Association between MRI findings and back pain after osteoporotic vertebral fractures: a multicenter prospective cohort study.

Ahmadi SA, Takahashi S, Hoshino M, Takayama K, Sasaoka R, Tsujio T, Yasuda H, Kanematsu F, Kono H, Toyoda H, Nakamura H.

Spine J. 2019 Feb 14. pii: S1529-9430(19)30056-7. doi: 10.1016/j.spinee.2019.02.007. [Epub ahead of print]

PMID:
30772505
8.

Interaction of nicotinic acetylcholine receptors with dopamine receptors in synaptic plasticity of the mouse insular cortex.

Toyoda H.

Synapse. 2019 Feb 14:e22094. doi: 10.1002/syn.22094. [Epub ahead of print]

PMID:
30767273
9.

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.

Kariyama K, Nouso K, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Wakuta A, Oonishi A, Kumada T, Kudo M, Group OBOTRPEFHRS, Group H.

Cancers (Basel). 2019 Feb 10;11(2). pii: E203. doi: 10.3390/cancers11020203.

10.

ISSLS PRIZE IN CLINICAL SCIENCE 2019: clinical importance of trunk muscle mass for low back pain, spinal balance, and quality of life-a multicenter cross-sectional study.

Hori Y, Hoshino M, Inage K, Miyagi M, Takahashi S, Ohyama S, Suzuki A, Tsujio T, Terai H, Dohzono S, Sasaoka R, Toyoda H, Kato M, Matsumura A, Namikawa T, Seki M, Yamada K, Habibi H, Salimi H, Yamashita M, Yamauchi T, Furuya T, Orita S, Maki S, Shiga Y, Inoue M, Inoue G, Fujimaki H, Murata K, Kawakubo A, Kabata D, Shintani A, Ohtori S, Takaso M, Nakamura H.

Eur Spine J. 2019 Feb 6. doi: 10.1007/s00586-019-05904-7. [Epub ahead of print]

PMID:
30729293
11.

Experimentally induced rhythmic jaw muscle activities during non-rapid eye movement sleep in freely moving guinea pigs.

Yamada KI, Higashiyama M, Toyoda H, Masuda Y, Kogo M, Yoshida A, Kato T.

J Sleep Res. 2019 Jan 23:e12823. doi: 10.1111/jsr.12823. [Epub ahead of print]

PMID:
30675746
12.

CD3+ B-1a Cells as a Mediator of Disease Progression in Autoimmune-Prone Mice.

Yamamoto W, Toyoda H, Xu DQ, Hanaki R, Morimoto M, Nakato D, Ito T, Iwamoto S, Bonno M, Tanaka S, Hirayama M.

Mediators Inflamm. 2018 Dec 23;2018:9289417. doi: 10.1155/2018/9289417. eCollection 2018.

13.

Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all-oral direct acting antivirals in patients with chronic hepatitis C virus infection.

Nakashima M, Toyoda H, Tada T, Mizuno K, Iio E, Tanaka Y, Sugiyama T, Yoshimura T, Kumada T.

Hepatol Res. 2019 Jan 10. doi: 10.1111/hepr.13311. [Epub ahead of print]

PMID:
30628746
14.

Microdetermination of Sialic Acids in Blood Samples by Hydrophilic Interaction Chromatography Coupled to Post-column Derivatization and Fluorometric Detection.

Nagai Y, Sakakibara I, Toyoda H.

Anal Sci. 2018 Dec 28. doi: 10.2116/analsci.18P500. [Epub ahead of print] No abstract available.

15.

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis.

Hiraoka A, Kumada T, Kariyama K, Takaguchi K, Atsukawa M, Itobayashi E, Tsuji K, Tajiri K, Hirooka M, Shimada N, Shibata H, Ishikawa T, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Itokawa N, Imai M, Joko K, Hiasa Y, Michitaka K; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 Jan;8(1):137-146. doi: 10.1002/cam4.1909. Epub 2018 Dec 21.

16.

Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.

Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, Deguchi A, Ishikawa T, Imai M, Ochi H, Joko K, Shimada N, Tajiri K, Hirooka M, Koizumi Y, Hiasa Y, Tanaka J.

J Gastroenterol Hepatol. 2018 Dec 14. doi: 10.1111/jgh.14564. [Epub ahead of print]

PMID:
30549320
17.

The association of back muscle strength and sarcopenia-related parameters in the patients with spinal disorders.

Toyoda H, Hoshino M, Ohyama S, Terai H, Suzuki A, Yamada K, Takahashi S, Hayashi K, Tamai K, Hori Y, Nakamura H.

Eur Spine J. 2019 Feb;28(2):241-249. doi: 10.1007/s00586-018-5858-8. Epub 2018 Dec 12.

PMID:
30542935
18.

Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.

Takada A, Ii N, Hirayama M, Toyoda H, Matsubara T, Toyomasu Y, Kawamura T, Daimon T, Sakuma H, Nomoto Y.

J Neurosurg Pediatr. 2018 Nov 23;23(3):317-324. doi: 10.3171/2018.9.PEDS18181.

PMID:
30497152
19.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.

Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Nakamuta M, Watanabe T, Tada T, Tsutsui A, Ikeda H, Abe H, Kato K, Uojima H, Ikegami T, Asano T, Kondo C, Koeda M, Okubo T, Arai T, Iwashita-Nakagawa A, Itokawa N, Kumada T, Iwakiri K.

Hepatol Res. 2018 Nov 28. doi: 10.1111/hepr.13292. [Epub ahead of print]

PMID:
30485638
20.

Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.

Tada T, Kumada T, Toyoda H, Kobayashi N, Sone Y, Oguri T, Kamiyama N.

AJR Am J Roentgenol. 2019 Feb;212(2):332-341. doi: 10.2214/AJR.18.20123. Epub 2018 Nov 26.

PMID:
30476453
21.

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.

Matsuura K, Aizawa N, Enomoto H, Nishiguchi S, Toyoda H, Kumada T, Iio E, Ito K, Ogawa S, Isogawa M, Alter HJ, Tanaka Y.

Open Forum Infect Dis. 2018 Oct 22;5(11):ofy268. doi: 10.1093/ofid/ofy268. eCollection 2018 Nov.

22.

Discontinuation of NTBC after liver transplantation in tyrosinemia type 1.

Kurihara K, Toyoda H, Amoano K, Inoue M, Uchida K, Sakurai H, Hayashi A, Hirayama M.

Pediatr Int. 2018 Nov;60(11):1039-1041. doi: 10.1111/ped.13697. Epub 2018 Oct 30. No abstract available.

PMID:
30375135
23.

The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study.

Toyoda H, Kumada T, Tada T, Mizuno K, Sone Y, Akita T, Tanaka J, Johnson PJ.

Liver Int. 2019 Mar;39(3):448-454. doi: 10.1111/liv.13987. Epub 2018 Nov 2.

PMID:
30312003
24.

Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.

Itokawa N, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, Abe H, Okubo T, Arai T, Iwashita AN, Kondo C, Mikami S, Asano T, Matsuzaki Y, Toyoda H, Kumada T, Iio E, Tanaka Y, Iwakiri K.

Hepatol Res. 2019 Feb;49(2):125-135. doi: 10.1111/hepr.13256. Epub 2018 Nov 13.

PMID:
30307682
25.

Anatomical analysis of the human ligamentum flavum in the thoracic spine: Clinical implications for posterior thoracic spinal surgery.

Ahmadi SA, Suzuki A, Terai H, Tamai K, Akhgar J, Hoshino M, Toyoda H, Rahmani MS, Hayashi K, Ohyama S, Takahashi S, Nakamura H.

J Orthop Sci. 2019 Jan;24(1):62-67. doi: 10.1016/j.jos.2018.08.023. Epub 2018 Sep 29.

PMID:
30279134
26.

A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Miyagawa T, Khor SS, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Shigematsu Y, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K.

J Hum Genet. 2018 Dec;63(12):1259-1267. doi: 10.1038/s10038-018-0518-8. Epub 2018 Sep 28.

PMID:
30266950
27.

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.

Chan AWH, Zhong J, Berhane S, Toyoda H, Cucchetti A, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, Lai PBS, Mazzaferro V, García-Fiñana M, Kudo M, Kumada T, Roayaie S, Johnson PJ.

J Hepatol. 2018 Dec;69(6):1284-1293. doi: 10.1016/j.jhep.2018.08.027. Epub 2018 Sep 18.

28.

Comparison of minimally invasive decompression and combined minimally invasive decompression and fusion in patients with degenerative spondylolisthesis with instability.

Hayashi K, Toyoda H, Terai H, Hoshino M, Suzuki A, Takahashi S, Tamai K, Ohyama S, Hori Y, Yabu A, Nakamura H.

J Clin Neurosci. 2018 Nov;57:79-85. doi: 10.1016/j.jocn.2018.08.032. Epub 2018 Aug 25.

PMID:
30154001
29.

Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.

Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Kondo C, Okubo T, Hiraoka A, Michitaka K, Fujioka S, Uojima H, Watanabe T, Ikeda H, Asano T, Ishikawa T, Matsumoto Y, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Mikami S, Tanaka Y, Kumada T, Iwakiri K.

J Gastroenterol Hepatol. 2019 Feb;34(2):364-369. doi: 10.1111/jgh.14447. Epub 2018 Sep 14.

PMID:
30144366
30.

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Nishimura D, Toyoda H, Kumada T, Goto H, Hirooka Y.

J Gastroenterol Hepatol. 2019 Jan;34(1):207-214. doi: 10.1111/jgh.14448. Epub 2018 Sep 18.

PMID:
30144360
31.

Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.

Hiraoka A, Kumada T, Kariyama K, Takaguchi K, Itobayashi E, Shimada N, Tajiri K, Tsuji K, Ishikawa T, Ochi H, Hirooka M, Tsutsui A, Shibata H, Tada T, Toyoda H, Nouso K, Joko K, Hiasa Y, Michitaka K; Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Hepatol Res. 2019 Jan;49(1):111-117. doi: 10.1111/hepr.13243. Epub 2018 Oct 9.

PMID:
30144256
32.

Enhanced cytotoxic effects of arsenite in combination with anthocyanidin compound, delphinidin, against a human leukemia cell line, HL-60.

Yoshino Y, Yuan B, Okusumi S, Aoyama R, Murota R, Kikuchi H, Takagi N, Toyoda H.

Chem Biol Interact. 2018 Oct 1;294:9-17. doi: 10.1016/j.cbi.2018.08.008. Epub 2018 Aug 17.

PMID:
30125548
33.

Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo.

Yuan B, Yao M, Wang X, Sato A, Okazaki A, Komuro H, Hayashi H, Toyoda H, Pei X, Hu X, Hirano T, Takagi N.

Cancer Cell Int. 2018 Aug 13;18:113. doi: 10.1186/s12935-018-0613-0. eCollection 2018.

34.

Cost-effectiveness of Balloon Kyphoplasty for Patients With Acute/Subacute Osteoporotic Vertebral Fractures in the Super-Aging Japanese Society.

Takahashi S, Hoshino M, Yasuda H, Terai H, Hayashi K, Tsujio T, Kono H, Suzuki A, Tamai K, Ohyama S, Toyoda H, Dohzono S, Kanematsu F, Hori Y, Nakamura H.

Spine (Phila Pa 1976). 2019 Mar 1;44(5):E298-E305. doi: 10.1097/BRS.0000000000002829.

PMID:
30086080
35.

Weekly Rituximab Followed by Monthly Rituximab Treatment for Autoimmune Disease Associated With RAS-associated Autoimmune Leukoproliferative Disease.

Toyoda H, Deguchi T, Iwamoto S, Kihira K, Hori H, Komada Y, Hirayama M.

J Pediatr Hematol Oncol. 2018 Nov;40(8):e516-e518. doi: 10.1097/MPH.0000000000001276.

PMID:
30080751
36.

Spinopelvic Sagittal Alignment after Microendoscopic Laminotomy in Patients with Lumbar Degenerative Spondylolisthesis.

Dohzono S, Toyoda H, Hori Y, Takahashi S, Suzuki A, Terai H, Nakamura H.

J Neurol Surg A Cent Eur Neurosurg. 2018 Nov;79(6):479-485. doi: 10.1055/s-0038-1666847. Epub 2018 Jul 30.

PMID:
30060261
37.

Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments.

Toyoda H, Kumada T, Tada T, Mizuno K, Sone Y, Kaneoka Y, Maeda A, Akita T, Tanaka J.

Aliment Pharmacol Ther. 2018 Sep;48(6):664-670. doi: 10.1111/apt.14914. Epub 2018 Jul 25.

PMID:
30047149
38.

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M.

Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20.

39.

Gastric adenocarcinoma coexisting with a reddish semipedunculated polyp arising from Helicobacter pylori-negative normal gastric mucosa: a report of two cases.

Isono Y, Baba Y, Mukai K, Asakawa H, Nose K, Tsuruga S, Tochio T, Kumazawa H, Tanaka H, Matsusaki S, Sase T, Saito T, Okano H, Toyoda H.

Clin J Gastroenterol. 2018 Dec;11(6):481-486. doi: 10.1007/s12328-018-0887-8. Epub 2018 Jul 18.

PMID:
30022297
40.

Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis.

Hiraoka A, Kumada T, Ogawa C, Kariyama K, Morita M, Nouso K, Toyoda H, Tada T, Ochi M, Murakami T, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Tomida H, Miyamoto Y, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Michitaka K.

J Gastroenterol Hepatol. 2019 Feb;34(2):436-441. doi: 10.1111/jgh.14378. Epub 2018 Jul 29.

PMID:
29996177
41.

Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.

Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y, Toyoda H, Kumada T, Hattori M, Katano Y, Goto H.

J Viral Hepat. 2018 Dec;25(12):1446-1451. doi: 10.1111/jvh.12967. Epub 2018 Jul 30.

PMID:
29993164
42.

Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.

Toyoda H, Kumada T, Tada T, Mizuno K, Hiraoka A, Tsuji K, Ishikawa T, Akita T, Tanaka J.

Liver Int. 2018 Dec;38(12):2260-2268. doi: 10.1111/liv.13927. Epub 2018 Jul 30.

PMID:
29981527
43.

Preoperative severity of facet joint degeneration does not impact the 2-year clinical outcomes and cervical imbalance following laminoplasty.

Tamai K, Suzuki A, Yabu A, Takahashi S, Toyoda H, Hoshino M, Terai H, Nakamura H.

Spine J. 2019 Feb;19(2):246-252. doi: 10.1016/j.spinee.2018.06.343. Epub 2018 Jun 27.

PMID:
29959100
44.

Balloon Kyphoplasty Versus Conservative Treatment for Acute Osteoporotic Vertebral Fractures With Poor Prognostic Factors: Propensity Score Matched Analysis Using Data From Two Prospective Multicenter Studies.

Hoshino M, Takahashi S, Yasuda H, Terai H, Watanabe K, Hayashi K, Tsujio T, Kono H, Suzuki A, Tamai K, Ohyama S, Toyoda H, Dohzono S, Kanematsu F, Hori Y, Nakamura H.

Spine (Phila Pa 1976). 2019 Jan 15;44(2):110-117. doi: 10.1097/BRS.0000000000002769.

PMID:
29958202
45.

A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.

Cai BB, Shi KQ, Li P, Chen BC, Shi L, Johnson PJ, Lai P, Toyoda H, Zhou MT.

Clin Chim Acta. 2018 Oct;485:187-194. doi: 10.1016/j.cca.2018.06.020. Epub 2018 Jun 15.

PMID:
29908940
46.

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment.

Matsumoto T, Wada H, Toyoda H, Hirayama M, Yamashita Y, Katayama N.

J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14190. [Epub ahead of print] No abstract available.

PMID:
29877044
47.

Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication.

Yasuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Toyoda H, Kumada T, Hirooka Y, Goto H.

J Gastroenterol Hepatol. 2018 Nov;33(11):1904-1911. doi: 10.1111/jgh.14280. Epub 2018 Jun 3.

PMID:
29744922
48.

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Toyoda H, Atsukawa M, Takaguchi K, Senoh T, Michitaka K, Hiraoka A, Fujioka S, Kondo C, Okubo T, Uojima H, Tada T, Yoneyama H, Watanabe T, Asano T, Ishikawa T, Tamai H, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Deguchi A, Itobayashi E, Mikami S, Moriya A, Okubo H, Tani J, Tsubota A, Tanaka Y, Masaki T, Iwakiri K, Kumada T.

J Gastroenterol. 2018 Dec;53(12):1276-1284. doi: 10.1007/s00535-018-1473-z. Epub 2018 May 8.

PMID:
29740665
49.

Inhibition of GluR Current in Microvilli of Sensory Neurons via Na+-Microdomain Coupling Among GluR, HCN Channel, and Na+/K+ Pump.

Kawasaki Y, Saito M, Won J, Bae JY, Sato H, Toyoda H, Kuramoto E, Kogo M, Tanaka T, Kaneko T, Oh SB, Bae YC, Kang Y.

Front Cell Neurosci. 2018 Apr 24;12:113. doi: 10.3389/fncel.2018.00113. eCollection 2018.

50.

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.

Matsumoto T, Toyoda H, Amano K, Hirayama M, Ishikawa E, Fujimoto M, Ito M, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Kawamura N, Ikejiri M, Kawakami K, Miyata T, Wada H.

Clin Appl Thromb Hemost. 2018 Nov;24(8):1301-1307. doi: 10.1177/1076029618771750. Epub 2018 Apr 25.

PMID:
29695177

Supplemental Content

Loading ...
Support Center